Increasingly, it is young professionals asking the same thing: "Doctor, can you start me on weight-loss drugs?" Recently, a ...
The results are likely to be more relevant to patients in sub-Saharan Africa than to those in high-resource settings, the authors say.
Scott Adams, creator of Dilbert, pleaded with President Donald Trump for help after his cancer diagnosis, Kennedy responded.
Erie Shores HealthCare (ESHC) marked a significant milestone today with the ribbon-cutting of its newly renovated Reflective ...
Syndax’s leadership in menin inhibition and CSF-1R inhibition – – Revumenib abstracts showcase compelling results in multiple acute leukemia subtypes across the R/R, frontline, and post-HSCT setting – ...
FRIENDSWOOD, Texas, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced its ...
Sarepta said on Monday that its late-stage study testing two gene-targeted therapies for Duchenne muscular dystrophy did not ...
Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced the launch of AdvanceAD-Tx™, a gene expression profile (GEP) test ...
An increasing volume of unused medicines are being returned by patients at a significant cost to the NHS, Surrey pharmacists ...
Sac-TMT will compete with two other TROP-2 targeted ADCs already approved: Gilead’s Trodelvy and AstraZeneca and Daiichi ...
Determining the type of diabetes a patient has at diagnosis can be challenging, and health care professionals should focus on each patient’s clinical condition when determining initial treatment, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback